Holen Sie sich die Stockscreener-App
27.52
0.66%
0.18
Vorhandelsmarkt:
27.60
0.08
+0.29%
Schlusskurs vom Vortag:
$27.34
Offen:
$27.4
24-Stunden-Volumen:
102.04K
Relative Volume:
0.81
Marktkapitalisierung:
$435.29M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-61.23M
KGV:
-2.0356
EPS:
-13.5194
Netto-Cashflow:
$22.49M
1W Leistung:
+2.69%
1M Leistung:
-18.14%
6M Leistung:
+48.36%
1J Leistung:
+95.59%
1-Tages-Spanne:
$26.95
$28.64
1-Wochen-Bereich:
$25.93
$28.64
52-Wochen-Spanne:
$7.75
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie ASMB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
27.52 | 432.44M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Guggenheim | Buy |
| 2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Short Covering: What is the target price for Assembly Biosciences Inc stock2025 Short Interest & Community Verified Swing Trade Signals - baoquankhu1.vn
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Price-Driven Insight from (ASMB) for Rule-Based Strategy - Stock Traders Daily
Sentiment Watch: Can Assembly Biosciences Inc disrupt its industryMarket Activity Report & Growth Focused Investment Plans - baoquankhu1.vn
Published on: 2026-01-26 23:16:19 - baoquankhu1.vn
Some Confidence Is Lacking In Assembly Biosciences, Inc. (NASDAQ:ASMB) As Shares Slide 27% - simplywall.st
Assembly Biosciences announces interim results from ABI-1179, ABI-5366 trials - MSN
Financial Survey: Assembly Biosciences (NASDAQ:ASMB) and Sol-Gel Technologies (NASDAQ:SLGL) - Defense World
Aug Volume: Should I trade or invest in Assembly Biosciences IncJuly 2025 Momentum & Reliable Entry Point Alerts - baoquankhu1.vn
Technical Analysis: What is Assembly Biosciences Incs 5 year growth outlookNew Guidance & Target Return Focused Stock Picks - baoquankhu1.vn
Returns Recap: Can Assembly Biosciences Inc disrupt its industryVolume Spike & Growth Oriented Trade Recommendations - baoquankhu1.vn
(ASMB) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Risks Report: What is the target price for Assembly Biosciences Inc stockTrade Performance Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Momentum Shift: How liquid is Assembly Biosciences Inc stockWeekly Profit Analysis & Community Trade Idea Sharing Platform - baoquankhu1.vn
Fed Meeting: Is Assembly Biosciences Inc benefiting from innovation trendsTrade Analysis Report & Consistent Profit Trading Strategies - baoquankhu1.vn
Exit Recap: Is Assembly Biosciences Inc impacted by rising ratesLayoff News & Smart Swing Trading Alerts - baoquankhu1.vn
Assembly Biosciences (ASMB) Sees Raised Price Target From Mizuho - GuruFocus
Gains Recap: What is the target price for Assembly Biosciences Inc stockEarnings Growth Report & High Accuracy Buy Signal Tips - baoquankhu1.vn
What are Assembly Biosciences Inc.’s earnings expectationsInsider Buying Signals & Free Real-Time Trading Alerts Every Day - bollywoodhelpline.com
Portfolio Recap: How Assembly Biosciences Inc stock reacts to inflationary pressures2025 Volatility Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ
Bull Run: Why Assembly Biosciences Inc V7B stock is a must watch tickerJuly 2025 WrapUp & Safe Swing Trade Setup Alerts - Bộ Nội Vụ
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in ‘significantly de-risks’ genital herpes programs - MSN
Assembly Biosciences (ASMB) price target increased by 24.84% to 48.70 - MSN
Assembly Biosciences (NASDAQ:ASMB) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
How strong is Assembly Biosciences Inc. stock revenue growthWeekly Profit Recap & Precise Trade Entry Recommendations - ulpravda.ru
Aug Sectors: How Assembly Biosciences Inc. stock reacts to global recession fearsPrice Action & Advanced Technical Signal Analysis - Улправда
How Assembly Biosciences Inc. stock reacts to global recession fearsPrice Action & Advanced Technical Signal Analysis - Улправда
Why Assembly Biosciences Inc. (V7B) stock is a must watch ticker2025 Stock Rankings & Consistent Growth Equity Picks - Улправда
Is Assembly Biosciences Inc. stock attractive after correction2025 AllTime Highs & Short-Term Trading Opportunity Alerts - Улправда
What risks investors should watch in Assembly Biosciences Inc. stockMarket Risk Analysis & Weekly High Conviction Ideas - ulpravda.ru
Assembly Biosciences Stock Faces Crucial Technical Test - AD HOC NEWS
Why Assembly Biosciences Inc. stock remains a top recommendation2026 world cup usa national team third place match star players low block defense winner prediction guide - ulpravda.ru
(ASMB) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Stock Price Up 4% – Time to Buy? - Defense World
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Trading 4% HigherHere's What Happened - MarketBeat
After 25 Years, Recurrent Genital Herpes Treatment Gains Corporate Partner - Vax-Before-Travel
Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for... - Medical Dialogues
Ellsworth Advisors LLC Acquires New Holdings in Assembly Biosciences, Inc. $ASMB - Defense World
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in 'significantly de-risks' genital herpes programs - MSN
Technical Reactions to ASMB Trends in Macro Strategies - Stock Traders Daily
With 32% ownership, Assembly Biosciences, Inc. (NASDAQ:ASMB) has piqued the interest of institutional investors - Yahoo Finance
Assembly Biosciences price target raised to $40 from $29 at Mizuho - MSN
Assembly Biosciences (NASDAQ:ASMB) Stock Price Down 6%What's Next? - MarketBeat
GILD Exercises Option to License Assembly Bio's Herpes Programs - WV News
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes - BioSpace
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Sahm
Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs - Asianet Newsable
Assembly Biosciences (NASDAQ:ASMB) Receives Buy Rating from HC Wainwright - Defense World
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says HC Wainwright - MSN
Gilead exercises option for Assembly Bio’s herpes treatment programs By Investing.com - Investing.com South Africa
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):